Platform brings efficiency to $75B Durable Medical Equipment market, significantly improving experience and trust of home-based care for patients
Tomorrow Health, the leading patient-first platform for home healthcare, today announced it has closed a $25 million Series A round of funding led by Andreessen Horowitz with participation from Obvious Ventures and BoxGroup. The company will utilize the new capital to hire additional talent and expand its infrastructure technology to seamlessly connect every patient with home-based care. In addition, the company announced Paul Mango, former Deputy Chief of Staff for Policy at HHS and Roy Beveridge, former Chief Medical Officer at Humana, have joined its Advisory Board.
With one in four aging people using durable medical equipment (DME) and 10 percent of COVID-19 patients experiencing ongoing symptoms, spending on DME is expected to reach more than $75B by 2021 in the United States. Tomorrow Health enables patients to get the equipment and supplies they require at home in a streamlined manner with accuracy, speed, and exceptional service. Partnering with payors, referring providers, and DME suppliers, Tomorrow Health provides a data-driven intelligence platform to match patients with high-quality DME suppliers based on insurance coverage, service quality, geography, and product specialization. Its dedicated team of Care Advocates offer support throughout the process, ensuring equipment and supplies are delivered when and where they are needed, with high-quality service and product transparency and education guaranteed every step of the way.
“We believe the home should be a patient’s primary point of care, and we are focused on providing patients with the right products, guidance and support to make that a reality,” said Vijay Kedar, co-founder and Chief Executive Officer of Tomorrow Health.
Source: Prnews
